Ballal Rahul D. (CIK 0001805097)

Latest company ownership

Shares held
4,106
Last filed at
Oct 10, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
2,302
Last filed at
Aug 13, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2024Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 7, 2024 Nov 12, 2024 AGIOS PHARMACEUTICALS, INC. Director Sell 5.0 -20,000 -28.67% ✓ $1.1M
Oct 8, 2024 Oct 10, 2024 Enliven Therapeutics, Inc. Director Sell 7.5 -10,420 -31.81% ✓ $293.6K
Apr 10, 2024 Apr 12, 2024 Enliven Therapeutics, Inc. Director Sell 5.0 -67,000 -36.71% ✓ $1.6M
Apr 4, 2024 Apr 8, 2024 Enliven Therapeutics, Inc. Director Sell 25.0 -3,485 -13.49% ✓ $66.7K
Apr 1, 2024 Apr 3, 2024 Enliven Therapeutics, Inc. Director Sell 25.0 -3,237 -12.66% ✓ $61.8K
Mar 20, 2024 Mar 22, 2024 Enliven Therapeutics, Inc. Director Sell 7.5 -13,278 -37.28% ✓ $254.5K
Feb 22, 2023 Feb 22, 2023 Enliven Therapeutics, Inc. CEO Sell 42.5 -32,861 -27.23% ✗ $153.1K
Jan 30, 2023 Feb 1, 2023 Enliven Therapeutics, Inc. CEO Sell 46.3 -11,313 -8.57% ✗ $44.2K
Dec 17, 2020 Dec 21, 2020 Enliven Therapeutics, Inc. CEO Sell 10.0 -4,999 -100.00% ✓ $125K
Dec 14, 2020 Dec 16, 2020 Enliven Therapeutics, Inc. CEO Sell 15.0 -1 -100.00% ✓ $25